Stockscreener 앱 받기
3.55
1.66%
-0.06
시장 영업 전:
4.09
0.54
+15.21%
Achieve Life Sciences Inc 주식(ACHV)의 최신 뉴스
H.C. Wainwright reiterates Buy on Achieve Life Sciences stock By Investing.com - Investing.com Canada
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions - Manufacturing Digital
Achieve Life Sciences Shares Fall After FDA Inspection Finds Violations - marketscreener.com
Achieve Life Sciences shifts cytisinicline production to U.S. By Investing.com - Investing.com India
Nicotine-dependence drug moves to Ohio production ahead of FDA refiling - Stock Titan
Achieve Life Sciences flags FDA observations while pushing launch to 2027 for smoking cessation med - MSN
Aug Big Picture: Is Achieve Life Sciences Inc stock forming a triangle patternInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
Nicotine dependence therapy research advances as Achieve Life Sciences, Inc. pushes for new solutions - Traders Union
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 earnings call transcript - MSN
Stock Recap: What is Achieve Life Sciences Incs book value per shareQuarterly Investment Review & AI Powered Market Entry Strategies - baoquankhu1.vn
Achieve Life Sciences, Inc. (ACHV) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by US manufacturing shift and AI-driven commercialization - MSN
Achieve Life Sciences reports fourth-quarter results in line with expectations - MSN
Q3 2025 Achieve Life Sciences Inc Earnings Call Transcript - GuruFocus
Live Achieve Life Sciences, Inc. (ACHV) Technical Analysis - Traders Union
Achieve Life Sciences, Inc. (ACHV) Stock Price Prediction for 2026, 2030-2040 - Traders Union
ACHV Technical Analysis & Stock Price Forecast - Intellectia AI
Achieve Life Sciences Inc (SP4P.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Achieve Life Sciences: The Recent Sell-Off Skews The Outcomes (NASDAQ:ACHV) - Seeking Alpha
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect - Finviz
In 3,014 subjects, Caris blood test reached 99.2% specificity - Stock Titan
Aug Analyst Calls: Will Achieve Life Sciences Inc benefit from government policyMarket Rally & Weekly Momentum Stock Picks - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Research Analysts Offer Predictions for ACHV FY2026 Earnings - Defense World
What is Zacks Research's Estimate for ACHV FY2026 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for ACHV Q1 Earnings? - Defense World
Aug Macro: Whats the fair value of Achieve Life Sciences Inc stockStock Surge & Smart Allocation Stock Reports - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV) - The Globe and Mail
Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping Cessation - Seeking Alpha
Achieve Life Sciences publishes cytisinicline receptor study By Investing.com - Investing.com Canada
Achieve Life Sciences publishes cytisinicline receptor study - Investing.com
Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med - Benzinga
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 Earnings Call Transcript - Insider Monkey
Achieve Life Sciences Announces Publication in Nicotine & - GlobeNewswire
Q1 Earnings Estimate for ACHV Issued By HC Wainwright - MarketBeat
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability - The Spec
Execution Risks Cloud Achieve Life Sciences’ Commercial Plans for Cytisinicline - The Globe and Mail
Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
HC Wainwright Reiterates "Buy" Rating for Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences (ACHV): HC Wainwright & Co. Reiterates Buy Rating | ACHV Stock News - GuruFocus
Achieve Life Sciences Reports 2025 Financial Results, Advances Cytisinicline NDA for Smoking and Vaping Cessation, Announces U.S. Manufacturing Partnership with Adare Pharma Solutions 12 - Minichart
Earnings Call Summary | Achieve Life(ACHV.US) Q4 2025 Earnings Conference - 富途牛牛
Achieve Life Sciences stock falls as commercial launch pushed to 2027 - ca.investing.com
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus
Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - MarketScreener
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV) - marketbeat.com
Achieve Life Sciences Q4 Earnings Call Highlights - MarketBeat
Achieve Life Sciences, Inc. 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights - Minichart
ACHV: Cytisinicline NDA accepted; U.S. launch planned for 1H 2027 with robust supply and payer strategy - TradingView — Track All Markets
2.69%
0.25%
자본화:
|
볼륨(24시간):